Literature DB >> 21263051

Comparison of the antibacterial properties of phage endolysins SAL-1 and LysK.

Soo Youn Jun1, Gi Mo Jung, Jee-Soo Son, Seong Jun Yoon, Yun-Jaie Choi, Sang Hyeon Kang.   

Abstract

In spite of the high degree of amino acid sequence similarity between the newly discovered phage endolysin SAL-1 and the phage endolysin LysK, SAL-1 has an approximately 2-fold-lower MIC against several Staphylococcus aureus strains and higher bacterial cell-wall-hydrolyzing activity than LysK. The amino acid residue change contributing the most to this enhanced enzymatic activity is a change from glutamic acid to glutamine at the 114th residue.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21263051      PMCID: PMC3067193          DOI: 10.1128/AAC.01097-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS).

Authors:  A P Johnson; H M Aucken; S Cavendish; M Ganner; M C Wale; M Warner; D M Livermore; B D Cookson
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

2.  Determination of minimum inhibitory concentrations.

Authors:  J M Andrews
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

3.  A single residue at the active site of CD38 determines its NAD cyclizing and hydrolyzing activities.

Authors:  R Graeff; C Munshi; R Aarhus; M Johns; H C Lee
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

Review 4.  Novel method to control pathogenic bacteria on human mucous membranes.

Authors:  Vincent A Fischetti
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

5.  Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci.

Authors:  Marianne Horgan; Gary O'Flynn; Jennifer Garry; Jakki Cooney; Aidan Coffey; Gerald F Fitzgerald; R Paul Ross; Olivia McAuliffe
Journal:  Appl Environ Microbiol       Date:  2008-12-01       Impact factor: 4.792

6.  LysK, the enzyme lysing Staphylococcus aureus cells: specific kinetic features and approaches towards stabilization.

Authors:  Lyubov Yu Filatova; Stephen C Becker; David M Donovan; Alexander K Gladilin; Natalia L Klyachko
Journal:  Biochimie       Date:  2010-02-06       Impact factor: 4.079

7.  Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase.

Authors:  J M Loeffler; D Nelson; V A Fischetti
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

8.  Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme.

Authors:  D Nelson; L Loomis; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

Review 9.  Staphylococcus epidermidis biofilms: importance and implications.

Authors:  James P O'Gara; Hilary Humphreys
Journal:  J Med Microbiol       Date:  2001-07       Impact factor: 2.472

10.  A bacteriolytic agent that detects and kills Bacillus anthracis.

Authors:  Raymond Schuch; Daniel Nelson; Vincent A Fischetti
Journal:  Nature       Date:  2002-08-22       Impact factor: 49.962

View more
  23 in total

Review 1.  Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.

Authors:  Hamed Haddad Kashani; Mathias Schmelcher; Hamed Sabzalipoor; Elahe Seyed Hosseini; Rezvan Moniri
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

2.  Efficacy of Intranasal Administration of the Recombinant Endolysin SAL200 in a Lethal Murine Staphylococcus aureus Pneumonia Model.

Authors:  Ji Yun Bae; Kang Il Jun; Chang Kyung Kang; Kyoung-Ho Song; Pyoeng Gyun Choe; Ji-Hwan Bang; Eu Suk Kim; Sang Won Park; Hong Bin Kim; Nam-Joong Kim; Wan Beom Park; Myoung-Don Oh
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

3.  Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredient.

Authors:  Soo Youn Jun; Gi Mo Jung; Seong Jun Yoon; Yun-Jaie Choi; Woo Suk Koh; Kyoung Sik Moon; Sang Hyeon Kang
Journal:  Antimicrob Agents Chemother       Date:  2014-01-21       Impact factor: 5.191

4.  In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin.

Authors:  Evgeny A Idelevich; Christof von Eiff; Alexander W Friedrich; Domenico Iannelli; Guoqing Xia; Georg Peters; Andreas Peschel; Ingrid Wanninger; Karsten Becker
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

5.  Efficient Killing of Planktonic and Biofilm-Embedded Coagulase-Negative Staphylococci by Bactericidal Protein P128.

Authors:  Nethravathi Poonacha; Sandhya Nair; Srividya Desai; Darshan Tuppad; Deepika Hiremath; Thulasi Mohan; Aradhana Vipra; Umender Sharma
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

6.  Nonconventional Therapeutics against Staphylococcus aureus.

Authors:  Caroline M Grunenwald; Monique R Bennett; Eric P Skaar
Journal:  Microbiol Spectr       Date:  2018-11

Review 7.  Implications of Bacteriophage- and Bacteriophage Component-Based Therapies for the Clinical Microbiology Laboratory.

Authors:  Katherine M Caflisch; Robin Patel
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

8.  Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection.

Authors:  Wan Beom Park; Hong Bin Kim; Nak-Hyun Kim; Jeong Eun Cho; Yoon Jeong Choi; Su Jin Choi; Soo Youn Jun; Chang Kyung Kang; Kyoung-Ho Song; Pyoeng Gyun Choe; Ji-Hwan Bang; Eu Suk Kim; Sang Won Park; Nam-Joong Kim; Myoung-Don Oh
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 9.  Antimicrobial bacteriophage-derived proteins and therapeutic applications.

Authors:  Dwayne R Roach; David M Donovan
Journal:  Bacteriophage       Date:  2015-06-23

10.  In silico modeling of the staphylococcal bacteriophage-derived peptidase CHAP(K).

Authors:  Mark Fenton; Jakki C Cooney; R Paul Ross; Roy D Sleator; Olivia McAuliffe; Jim O'Mahony; Aidan Coffey
Journal:  Bacteriophage       Date:  2011-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.